Home > Boards > US Listed > Biotechs > Akari Therapeutics (AKTX)

lets get the show on the road already!!!!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BrazenBull Member Profile
 
Followed By 125
Posts 8,109
Boards Moderated 4
Alias Born 11/14/12
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/19/2019 4:05:56 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/14/2019 8:01:05 AM
Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related... GlobeNewswire Inc. - 8/14/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/9/2019 8:53:15 AM
Akari Therapeutics announces new data demonstrating synergistic benefits of nomacopan’s bifunctional C5 and LTB4 inhibitory... GlobeNewswire Inc. - 8/9/2019 8:30:00 AM
Securities Registration (foreign Private Issuer) (f-1) Edgar (US Regulatory) - 8/6/2019 4:41:24 PM
Akari Therapeutics Announces Oral Presentation of Nomacopan Phase II Data in Patients with Bullous Pemphigoid at the 28th Eur... GlobeNewswire Inc. - 7/31/2019 9:57:21 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 7/12/2019 4:33:02 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/2/2019 4:26:53 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/2/2019 4:26:46 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/28/2019 4:38:34 PM
Akari Therapeutics, Plc Announces $4.5 Million Registered Direct Offering GlobeNewswire Inc. - 6/28/2019 9:22:39 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/27/2019 4:34:05 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/25/2019 4:32:48 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/19/2019 4:32:03 PM
Akari Therapeutics’ Nomacopan Demonstrates Positive Early Safety and Efficacy in Phase I/II Clinical Study in Moderate-to-S... GlobeNewswire Inc. - 6/19/2019 7:39:18 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/6/2019 5:17:18 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/29/2019 4:17:15 PM
Akari Therapeutics Reports First Quarter 2019 Financial Results And Highlights Recent Clinical Progress GlobeNewswire Inc. - 5/29/2019 7:45:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/29/2019 7:01:21 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/29/2019 5:26:15 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/26/2019 1:35:18 PM
Akari Therapeutics Announces Expanded Ophthalmology Program Based on Positive Emerging Data on LTB4-C5 Dual Action in Surface... GlobeNewswire Inc. - 4/26/2019 8:48:59 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 4/23/2019 5:25:17 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/23/2019 5:24:56 PM
BrazenBull   Wednesday, 07/25/18 08:21:40 AM
Re: makingbiigdough post# 176
Post # of 453 
lets get the show on the road already!!!!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist